Filtered By:
Condition: Hypertension
Procedure: Transplants

This page shows you your search results in order of relevance. This is page number 13.

Order by Relevance | Date

Total 198 results found since Jan 2013.

Pulmonary artery compliance in different forms of pulmonary hypertension
Conclusion PAC was similar between PH groups and was not an independent predictor of transplant-free survival in PAH. RC time was different between PH subgroups, challenging RC time constancy. Trial registration number NCT04071327
Source: Heart - June 26, 2023 Category: Cardiology Authors: McCormick, A., Krishnan, A., Badesch, D., Benza, R. L., Bull, T. M., De Marco, T., Feldman, J., Hemnes, A. R., Hirsch, R., Horn, E., Kennedy, J., Mathai, S. C., McConnell, W., Pugliese, S. C., Sager, J. S., Shlobin, O. A., Simon, M. A., Lammi, M. R. Tags: Pulmonary vascular disease Source Type: research

Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system
CONCLUSIONS: The current CML treatment target is a cure that leads to normal age and gender-adjusted survival with a "normal" quality of life. Cardiovascular disorders are one of the major obstacles to reaching this target in CML patients. The treatment choices for CML patients must include a cardiovascular perspective.PMID:37401285 | DOI:10.26355/eurrev_202306_32786
Source: European Review for Medical and Pharmacological Sciences - July 4, 2023 Category: Drugs & Pharmacology Authors: U Y Malkan I C Haznedaroglu Source Type: research

Ventricular global function index is associated with clinical outcomes in pediatric pulmonary hypertension
CONCLUSIONS: RV GFI was associated with CAO in this cohort, and inclusion in multivariable models had increased predictive value compared to RVEF. GFI uses readily available CMR data without additional post-processing and may provide additional prognostic value in pediatric PH patients beyond traditional CMR markers.PMID:37400886 | PMC:PMC10316558 | DOI:10.1186/s12968-023-00947-8
Source: Atherosclerosis - July 3, 2023 Category: Cardiology Authors: Hieu T Ta Paul J Critser Michal Sch äfer Nicholas J Ollberding Michael D Taylor Michael V Di Maria Russel Hirsch D Dunbar Ivy Benjamin S Frank Source Type: research

Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system
CONCLUSIONS: The current CML treatment target is a cure that leads to normal age and gender-adjusted survival with a "normal" quality of life. Cardiovascular disorders are one of the major obstacles to reaching this target in CML patients. The treatment choices for CML patients must include a cardiovascular perspective.PMID:37401285 | DOI:10.26355/eurrev_202306_32786
Source: Pharmacological Reviews - July 4, 2023 Category: Drugs & Pharmacology Authors: U Y Malkan I C Haznedaroglu Source Type: research

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease
CONCLUSIONS: There is currently insufficient evidence to determine the effectiveness of ACEi or ARB in patients with stage 1 to 3 CKD who do not have DM. The available evidence is overall of very low certainty and high risk of bias. We have identified an area of large uncertainty for a group of patients who account for most of those diagnosed as having CKD.PMID:37466151 | DOI:10.1002/14651858.CD007751.pub3
Source: Cochrane Database of Systematic Reviews - July 19, 2023 Category: General Medicine Authors: Tess E Cooper Claris Teng David J Tunnicliffe Brydee A Cashmore Giovanni Fm Strippoli Source Type: research